Urology, Heidelberg

Semi-Live • Heidelberg • 2024 youtu.be/pSHGI1_op5Y

Semi-Live 2022 GLOBAL (March 2-5, 2022): Join wherever you are! State of the Art in Urologic Surgery: View, discuss, reflect, contemplate, chat and earn CME's! Limitless due to opportunity! Program and Registration: semi-live.org youtube.com/watch?v=KGmR6W…

Invitation to “Semi-Live 2022” in Heidelberg! Registration is open! Early bird discount until December 15, 2021. All info here: semi-live.org

State-of-the-art staging of high risk prostate cancer for subsequent local therapy: replacement of CT and bone scan by PSMA-PET. thelancet.com/journals/lance…

Radiotherapy (RT) following radical prostatectomy: early salvage RT (PSA 0.2 ng/ml) vs.adjuvant RT reduces over-treatment by 50% with concomitant reduction of functional morbidities without compromising oncological safety. thelancet.com/journals/lanon…

RAVES or the end of adjuvant radiotherapy in high-risk prostate cancer: early salvage radiotherapy +/- equally effective if delivered at a PSA of < / = 0.2. PS: Indicate PSMA-PET in BCR! thelancet.com/pdfs/journals/…

Precision oncology for individualized treatment in men with newly diagnosed high-risk prostate cancer: targeted next generation sequencing using a DNA damage repair and checkpoint gene panel. sciencedirect.com/science/articl…

Radical prostatectomy for high risk prostate cancer: excellent continence with the Bocciardi Retzius-sparing trans Douglas technique. bmcurol.biomedcentral.com/track/pdf/10.1…

Metastatic Castration-Resistant Prostate Cancer: FDA approval for Rucaparib • as a treatment option for non-BRCA DNA damage repair gene alterations. clincancerres.aacrjournals.org/content/early/…

TREXIT: the end of transrectal prostate biopsy nature.com/articles/s4139…

TREXIT: The start to end transrectal prostate biopsy auajournals.org/doi/10.1016/j.…

TREXIT: Emphysematous Prostatitis With Secondary Psoas Abscess—A Lethal Outcome Following (Transrectal) Prostate Biopsy. goldjournal.net/article/S0090-…

Metastatic castration-resistant prostate cancer in men with homologous recombination repair genomics: RCT-proven efficacy of olaparib. nejm.org/doi/full/10.10…

A big step in understanding genetic-associated health & disease. The genome aggregation database (gnomAD)of whole-genome sequences (+ 125,748 exomes) from 15,708 people. With SNV‘s & structural variants like deletions, inversions or duplications of DNA. nature.com/articles/d4158…